These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34380549)

  • 41. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
    Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and patient related factors associated with Extended-Spectrum Beta-Lactamase producing Escherichia coli and Klebsiella pneumoniae carriage and infection among pediatric patients in Tanzania.
    Letara N; Ngocho JS; Karami N; Msuya SE; Nyombi B; Kassam NA; Skovbjerg S; Åhren C; Philemon R; Mmbaga BT
    Sci Rep; 2021 Nov; 11(1):22759. PubMed ID: 34815472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk Factors and Molecular Features of Sequence Type (ST) 131 Extended-spectrum β-Lactamase-producing Escherichia coli in Community-onset Bacteremia.
    Kim H; Kim YA; Park YS; Choi MH; Lee GI; Lee K
    Sci Rep; 2017 Nov; 7(1):14640. PubMed ID: 29116143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
    Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Ruíz M; Peña C; Almela M; Almirante B; Grill F; Colomina J; Giménez M; Oliver A; Horcajada JP; Navarro G; Coloma A; Pascual A;
    Clin Infect Dis; 2010 Jan; 50(1):40-8. PubMed ID: 19995215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland.
    Kuster SP; Hasse B; Huebner V; Bansal V; Zbinden R; Ruef C; Ledergerber B; Weber R
    Infection; 2010 Feb; 38(1):33-40. PubMed ID: 20108162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.
    Søraas A; Sundsfjord A; Sandven I; Brunborg C; Jenum PA
    PLoS One; 2013; 8(7):e69581. PubMed ID: 23936052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increasing Prevalence of Pediatric Community-acquired UTI by Extended Spectrum β-Lactamase-producing E. coli: Cause for Concern.
    Collingwood JD; Yarbrough AH; Boppana SB; Dangle PP
    Pediatr Infect Dis J; 2023 Feb; 42(2):106-109. PubMed ID: 36638394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of Factors Associated With Community-Acquired Extended-Spectrum β-Lactamase-Producing Escherichia coli Urinary Tract Infections in France.
    Paumier A; Asquier-Khati A; Thibaut S; Coeffic T; Lemenand O; Larramendy S; Leclère B; Caillon J; Boutoille D; Birgand G;
    JAMA Netw Open; 2022 Sep; 5(9):e2232679. PubMed ID: 36129706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Characterization and molecular epidemiology of ESBL in Escherichia coli and Klebsiella pneumoniae in 11 Spanish hospitals (2004)].
    Diestra K; Coque TM; Miró E; Oteo J; Nicolau CJ; Campos J; Moyá B; Curiao T; Pérez-Vázquez M; Cantón R; Oliver A; Navarro F;
    Enferm Infecc Microbiol Clin; 2008; 26(7):404-10. PubMed ID: 18842234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High Burden of Extended-Spectrum β-Lactamase-Producing
    Sawatwong P; Sapchookul P; Whistler T; Gregory CJ; Sangwichian O; Makprasert S; Jorakate P; Srisaengchai P; Thamthitiwat S; Promkong C; Nanvatthanachod P; Vanaporn M; Rhodes J
    Am J Trop Med Hyg; 2019 Apr; 100(4):943-951. PubMed ID: 30793684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli.
    Melzer M; Petersen I
    J Infect; 2007 Sep; 55(3):254-9. PubMed ID: 17574678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of the COVID-19 pandemic on extended-spectrum β-lactamase producing Escherichia coli in urinary tract and blood stream infections: results from a nationwide surveillance network, Finland, 2018 to 2022.
    Ilmavirta H; Ollgren J; Räisänen K; Kinnunen T; Hakanen AJ; Rantakokko-Jalava K; Jalava J; Lyytikäinen O
    Antimicrob Resist Infect Control; 2024 Jul; 13(1):72. PubMed ID: 38971782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China.
    Ni Q; Tian Y; Zhang L; Jiang C; Dong D; Li Z; Mao E; Peng Y
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):428-433. PubMed ID: 27681363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increasing community prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in urine is associated with increasing district-level antibiotic consumption.
    Nunes LHS; Ribeiro VST; Salviato RB; de Andrade AP; Suss PH; Vicenzi FJ; Hino AAF; Telles JP; Tuon FF
    FEMS Microbiol Lett; 2024 Jan; 371():. PubMed ID: 38821516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae fecal carriage among children under five years in Addis Ababa, Ethiopia.
    Tola MA; Abera NA; Gebeyehu YM; Dinku SF; Tullu KD
    PLoS One; 2021; 16(10):e0258117. PubMed ID: 34597328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand.
    Anunnatsiri S; Towiwat P; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1169-77. PubMed ID: 23431823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and risk factors of extended-spectrum beta-lactamase producing E. coli causing urinary tract infections in Iceland during 2012-2021.
    Halldórsdóttir AM; Hrafnkelsson B; Einarsdóttir K; Kristinsson KG
    Eur J Clin Microbiol Infect Dis; 2024 Sep; 43(9):1689-1697. PubMed ID: 38935227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing
    Zhu FH; Rodado MP; Asmar BI; Salimnia H; Thomas R; Abdel-Haq N
    Infect Dis (Lond); 2019; 51(11-12):802-809. PubMed ID: 31429616
    [No Abstract]   [Full Text] [Related]  

  • 59. FACTORS ASSOCIATED WITH EXTENDED SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI IN COMMUNITY-ACQUIRED URINARY TRACT INFECTION AT HOSPITAL EMERGENCY DEPARTMENT, BANGKOK, THAILAND.
    Savatmorigkorngul S; Poowarattanawiwit P; Sawanyawisuth K; Sittichanbuncha Y
    Southeast Asian J Trop Med Public Health; 2016 Mar; 47(2):227-33. PubMed ID: 27244961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective cohort study of risk factors for extended-spectrum ß-lactamase-producing Escherichia coli urinary tract infections in elderly patients admitted to hospital.
    Artero A; Esparcia A; Alberola J; Madrazo M; Nogueira JM; Eiros JM
    Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28873266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.